Form 8-K, current report
Hepion Pharmaceuticals, Inc., 8-K filed 2026-09-08
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
8-K filed with the Securities and Exchange Commission by Hepion Pharmaceuticals, Inc. (CIK 0001583771) on 2026-09-08.
Accession number 0001493152-26-041801. EDGAR reports the filing package as 945 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-index.htm.
Items reported on the cover
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits